141 related articles for article (PubMed ID: 15243031)
1. The effect of the beta2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the rat.
Jones SW; Baker DJ; Gardiner SM; Bennett T; Timmons JA; Greenhaff PL
J Pharmacol Exp Ther; 2004 Dec; 311(3):1225-31. PubMed ID: 15243031
[TBL] [Abstract][Full Text] [Related]
2. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
Bricout VA; Serrurier BD; Bigard AX
Acta Physiol Scand; 2004 Mar; 180(3):271-80. PubMed ID: 14962009
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with the beta(2)-adrenoceptor agonist prodrug BRL-47672 impairs rat skeletal muscle function by inducing a comprehensive shift to a faster muscle phenotype.
Baker DJ; Constantin-Teodosiu D; Jones SW; Timmons JA; Greenhaff PL
J Pharmacol Exp Ther; 2006 Oct; 319(1):439-46. PubMed ID: 16844843
[TBL] [Abstract][Full Text] [Related]
4. Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres.
Oishi Y; Imoto K; Ogata T; Taniguchi K; Matsumoto H; Roy RR
Acta Physiol Scand; 2002 Dec; 176(4):311-8. PubMed ID: 12444937
[TBL] [Abstract][Full Text] [Related]
5. Effects of clenbuterol and cyclosporin A on the myosin heavy chain mRNA level and the muscle mass in rat masseter.
Arai C; Ohnuki Y; Umeki D; Hirashita A; Saeki Y
J Physiol Sci; 2006 Jun; 56(3):205-9. PubMed ID: 16839454
[TBL] [Abstract][Full Text] [Related]
6. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
7. [Expression of myosin heavy chain IIx mRNA as a molecular marker of disuse of soleus muscle in rats].
Wang YY; Yu ZB; Xie MJ; Feng HZ; Gao F
Space Med Med Eng (Beijing); 2002 Aug; 15(4):260-4. PubMed ID: 12422865
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of myosin heavy chain MHClalpha in rat muscles after unweighting and clenbuterol treatment.
Stevens L; Gohlsch B; Mounier Y; Pette D
Biochem Biophys Res Commun; 2000 Aug; 275(2):418-21. PubMed ID: 10964680
[TBL] [Abstract][Full Text] [Related]
9. [Effects of inosine injection in expression of myosin heavy chain in intrafusal and extrafusal myofibers in soleus muscle of tail-suspended rats].
Shi L; Fan XL; Wu SD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):318-20. PubMed ID: 16643789
[TBL] [Abstract][Full Text] [Related]
10. Heart failure alters MyoD and MRF4 expressions in rat skeletal muscle.
Carvalho RF; Cicogna AC; Campos GE; Lopes Fda S; Sugizaki MM; Nogueira CR; Pai-Silva MD
Int J Exp Pathol; 2006 Jun; 87(3):219-25. PubMed ID: 16709230
[TBL] [Abstract][Full Text] [Related]
11. Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol.
Kitaura T; Tsunekawa N; Hatta H
J Appl Physiol (1985); 2001 Jul; 91(1):85-90. PubMed ID: 11408417
[TBL] [Abstract][Full Text] [Related]
12. Ractopamine induces differential gene expression in porcine skeletal muscles.
Gunawan AM; Richert BT; Schinckel AP; Grant AL; Gerrard DE
J Anim Sci; 2007 Sep; 85(9):2115-24. PubMed ID: 17468428
[TBL] [Abstract][Full Text] [Related]
13. Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy.
Mozdziak PE; Greaser ML; Schultz E
J Appl Physiol (1985); 1998 Apr; 84(4):1359-64. PubMed ID: 9516204
[TBL] [Abstract][Full Text] [Related]
14. [The effect of MyoD family proteins on muscular atrophy induced by brachial plexus injury in rats].
Wu Z; Jin H; Gu Y
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):561-3. PubMed ID: 12133506
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury.
Ryall JG; Schertzer JD; Alabakis TM; Gehrig SM; Plant DR; Lynch GS
J Appl Physiol (1985); 2008 Jul; 105(1):165-72. PubMed ID: 18436698
[TBL] [Abstract][Full Text] [Related]
16. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers.
von Deutsch DA; Abukhalaf IK; Wineski LE; Aboul-Enein HY; Pitts SA; Parks BA; Oster RA; Paulsen DF; Potter DE
Chirality; 2000 Aug; 12(8):637-48. PubMed ID: 10897101
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot-Marie-Tooth disease.
Smith CA; Chetlin RD; Gutmann L; Yeater RA; Alway SE
Muscle Nerve; 2006 Nov; 34(5):586-94. PubMed ID: 16881064
[TBL] [Abstract][Full Text] [Related]
18. Effects of 84-days of bedrest and resistance training on single muscle fibre myosin heavy chain distribution in human vastus lateralis and soleus muscles.
Gallagher P; Trappe S; Harber M; Creer A; Mazzetti S; Trappe T; Alkner B; Tesch P
Acta Physiol Scand; 2005 Sep; 185(1):61-9. PubMed ID: 16128698
[TBL] [Abstract][Full Text] [Related]
19. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
George I; Xydas S; Mancini DM; Lamanca J; DiTullio M; Marboe CC; Shane E; Schulman AR; Colley PM; Petrilli CM; Naka Y; Oz MC; Maybaum S
J Heart Lung Transplant; 2006 Sep; 25(9):1084-90. PubMed ID: 16962470
[TBL] [Abstract][Full Text] [Related]
20. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
Bonnet N; Benhamou CL; Brunet-Imbault B; Arlettaz A; Horcajada MN; Richard O; Vico L; Collomp K; Courteix D
Bone; 2005 Nov; 37(5):622-33. PubMed ID: 16157516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
